HOME › DRUGS › ABACAVIR, DOLUTEGRAVIR, LAMIVUDINE
ACTIVE SUBSTANCE / INN

ABACAVIR, DOLUTEGRAVIR, LAMIVUDINE

Brand name(s): ABACAVIR, DOLUTEGRAVIR AND LAMIVUDINE, ABACAVIR, DOLUTEGRAVIR, LAMIVUDINE
FDA LISTED
NONE (TENTATIVE APPROVAL)
ANDA210391
ANDA217830
ACTIVE SUBSTANCE
Abacavir, Dolutegravir, Lamivudine
REGULATORS
FDA
SPONSORS / MAH
CIPLA LIMITED, MACLEODS PHARMACEUTICALS LTD
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
ABACAVIR, DOLUTEGRAVIR, LAMIVUDINEANDA210391CIPLA LIMITEDNone (Tentative Approval)
ABACAVIR, DOLUTEGRAVIR AND LAMIVUDINEANDA217830MACLEODS PHARMACEUTICALS LTDNone (Tentative Approval)

FULL INTELLIGENCE ON ABACAVIR, DOLUTEGRAVIR, LAMIVUDINE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →